Jump to content

Alifedrine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by OAbot (talk | contribs) at 23:50, 29 January 2023 (Open access bot: doi added to citation with #oabot.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Alifedrine
Names
Preferred IUPAC name
1-Cyclohexyl-3-{[(1R,2S)-1-hydroxy-1-phenylpropan-2-yl]amino}propan-1-one
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
UNII
  • InChI=1S/C18H27NO2/c1-14(18(21)16-10-6-3-7-11-16)19-13-12-17(20)15-8-4-2-5-9-15/h3,6-7,10-11,14-15,18-19,21H,2,4-5,8-9,12-13H2,1H3/t14-,18-/m0/s1
    Key: UEELVIXXTBPOCF-KSSFIOAISA-N
  • InChI=1/C18H27NO2/c1-14(18(21)16-10-6-3-7-11-16)19-13-12-17(20)15-8-4-2-5-9-15/h3,6-7,10-11,14-15,18-19,21H,2,4-5,8-9,12-13H2,1H3/t14-,18-/m0/s1
    Key: UEELVIXXTBPOCF-KSSFIOAIBT
  • C[C@@H]([C@@H](C1=CC=CC=C1)O)NCCC(=O)C2CCCCC2
Properties
C18H27NO2
Molar mass 289.419 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Alifedrine is a partial beta-adrenergic agonist.[1]

References

  1. ^ Metzenauer, P.; Dedecke, R.; Göbel, H.; Martorana, P. A.; Stroman, F.; Szelenyi, I. (1989). "Effects of the novel beta-adrenergic partial agonist alifedrine on cardiac performance in dogs with acute ischemic left ventricular failure". Journal of Cardiovascular Pharmacology. 14 (1): 103–8. doi:10.1097/00005344-198907000-00018. PMID 2475700. S2CID 72099344.